Insights

Search across every press release, SEC filing, FDA approval, analyst rating, and insider trade. Filter by company, sector, source, category, or date range.

Switch to live feed

Filters

Search title or summary

Date range

Companies

Sectors

Industries

Sources

Categories

25+ resultsLive feed →

PR13:00:00·16h·Health Care·
$PLSE
Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026
Multicenter results show sustained high durability and procedural efficiency, redefining positive expectations for catheter ablation in patients with atrial fibrillation Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking positive clinical data from its nPulse Cardiac Catheter System first-in-human feasibility study at the Heart Rhythm 2026 meeting. The late-breaking presentation included incremental participant follow up data. Building upon the previously reported data set presented at the AF Symposium meeting in February of 2026, the expanded 6-
PR12:30:00·16h·Health Care·
$ABT
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
Four late-breaking presentations at Heart Rhythm Society 2026 in Chicago highlight strong clinical evidence across Abbott's growing pulsed field ablation and novel cardiac pacing portfoliosSix-month results from the FlexPulse IDE study for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™, reveal positive outcomes for treating complex AFib casesNew data from the Volt CE Mark Extension Cohort trial for the Volt™ PFA System, demonstrate the strong safety, efficacy and efficiency of treatment of AFib cases for posterior wall ablationTwo new conduction system pacing studies showcase initial results of Abbott's investigational UltiSynq™ CSP implantable cardioverter-defibrillator lead and a fi
PR12:30:00·16h·Health Care·
$MDT
Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues
HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of the Sphere-9 catheter for treatment of VT; U.S. pivotal trial approved by FDANew at HRS: data show consistent durability for the Sphere-360 catheter across patient anatomies; Sphere-360 approved in CE Mark geographiesFirst patients enrolled in Conquer-AF trial to evaluate the Sphere-9 catheter for repeat atrial fibrillation proceduresGALWAY, Ireland and CHICAGO, April 25, 2026 /PRNewswire/ -- Medtronic plc, (NYSE:MDT), a global leader in healthcare technology, today announc
PR03:00:00·1d·Technology·
$PONY
Pony.ai Announces New Generation Autonomous Driving Compute Platform Built on NVIDIA DRIVE Hyperion
GUANGZHOU, China, April 25, 2026 /PRNewswire/ -- Pony AI Inc. ("Pony.ai") (NASDAQ:PONY, HKEX: 2026)) today announced its new generation autonomous driving domain controller, a high-performance compute system designed for both Pony.ai's L4 autonomous driving platform and a broader set of customer applications across autonomous mobility. Developed in collaboration with NVIDIA, the new controller is built on the NVIDIA DRIVE Hyperion platform and powered by NVIDIA DRIVE AGX Thor with NVIDIA NVLink, supporting Pony.ai's next phase of commercialization in robotaxis and its growing domain controller business. The new system is designed to deliver significant gains in AI computing performance, ener
INSIDER21:35:59·1d·Real Estate·
$STRS
Large owner Oasis Management Co Ltd. sold $313,792 worth of shares (10,493 units at $29.90) (SEC Form 4)
4 - STRATUS PROPERTIES INC (0000885508) (Issuer)
INSIDER21:35:45·1d·Technology·
$WULF
Chief Strategy Officer Langlais Kerri M. converted options into 327,054 shares and returned 180,860 shares to the company, increasing direct ownership by 4% to 3,864,493 units (SEC Form 4)
4 - TERAWULF INC. (0001083301) (Issuer)
INSIDER21:35:19·1d·Technology·
$WULF
Chief Executive Officer Prager Paul B. converted options into 981,162 shares and returned 542,582 shares to the company, increasing direct ownership by 66% to 1,101,020 units (SEC Form 4)
4 - TERAWULF INC. (0001083301) (Issuer)
INSIDER21:34:57·1d·Technology·
$WULF
Chief Financial Officer Fleury Patrick returned 128,695 shares to the company and converted options into 327,054 shares, increasing direct ownership by 6% to 3,608,801 units (SEC Form 4)
4 - TERAWULF INC. (0001083301) (Issuer)
INSIDER21:34:34·1d·Technology·
$WULF
Chief Technology Officer Khan Nazar M. converted options into 817,635 shares and sold 452,152 shares, increasing direct ownership by 98% to 738,626 units (SEC Form 4)
4 - TERAWULF INC. (0001083301) (Issuer)
SEC21:31:40·1d·Health Care·
$ADCT
Amendment: SEC Form SCHEDULE 13G/A filed by ADC Therapeutics SA
SCHEDULE 13G/A - ADC Therapeutics SA (0001771910) (Subject)
INSIDER21:30:06·1d·Health Care·
$MNKD
Chief Financial Officer Prentiss Christopher B covered exercise/tax liability with 12,267 shares, decreasing direct ownership by 3% to 338,924 units (SEC Form 4) to satisfy tax liability
4 - MANNKIND CORP (0000899460) (Issuer)
INSIDER21:29:49·1d·Health Care·
$ORGO
Chief Commercial Officer Grow Brian exercised 958 shares at a strike of $1.24, increasing direct ownership by 0.11% to 900,682 units (SEC Form 4)
4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
SEC21:28:23·1d·Health Care·
$NRIX
Amendment: SEC Form SCHEDULE 13G/A filed by Nurix Therapeutics Inc.
SCHEDULE 13G/A - Nurix Therapeutics, Inc. (0001549595) (Subject)
INSIDER21:17:59·1d·Technology·
$CVLT
SEC Form 4 filed by Chief Accounting Officer Abrahamsen Danielle Nicole
4 - COMMVAULT SYSTEMS INC (0001169561) (Issuer)
INSIDER21:17:50·1d·Technology·
$CVLT
SEC Form 4 filed by President & CEO Mirchandani Sanjay
4 - COMMVAULT SYSTEMS INC (0001169561) (Issuer)
INSIDER21:17:55·1d·Technology·
$CVLT
SEC Form 4 filed by Chief Financial Officer Merrill Gary
4 - COMMVAULT SYSTEMS INC (0001169561) (Issuer)
INSIDER21:12:09·1d·Health Care·
$SNYR
Director Kaushal Nitin was granted 306,433 shares (SEC Form 4)
4 - Synergy CHC Corp. (0001562733) (Issuer)
INSIDER21:10:03·1d·Consumer Discretionary·
$NMM
Officer Frangou Angeliki bought $251,999 worth of Common Unit (3,597 units at $70.06) (SEC Form 4)
4 - Navios Maritime Partners L.P. (0001415921) (Issuer)
INSIDER21:05:48·1d·Consumer Discretionary·
$PLBY
General Counsel & Secretary Riley Christopher sold $16,218 worth of shares (8,916 units at $1.82), decreasing direct ownership by 0.47% to 1,870,249 units (SEC Form 4) (withholding obligation)
4 - Playboy, Inc. (0001803914) (Issuer)
INSIDER21:05:55·1d·Consumer Discretionary·
$PLBY
CEO & President Kohn Bernhard L Iii sold $33,785 worth of shares (18,502 units at $1.83), decreasing direct ownership by 0.30% to 6,245,045 units (SEC Form 4) (for tax liability)
4 - Playboy, Inc. (0001803914) (Issuer)
PR20:45:00·1d·Industrials·
$CPAC
Cementos Pacasmayo S.A.A. Announces Consolidated Results for First Quarter 2026
Cementos Pacasmayo S.A.A. and subsidiaries (NYSE:CPAC, BVL: CPACASC1)) ("the Company" or "Pacasmayo"), a leading cement company serving the Peruvian construction industry, announced today its consolidated results for the first quarter ("1Q26"). These results have been prepared in accordance with International Financial Reporting Standards ("IFRS") and are stated in Soles (S/). 1Q26 FINANCIAL AND OPERATIONAL HIGHLIGHTS: (All comparisons are to 1Q25, unless otherwise stated) Sales volume of cement, concrete and precast increased by 11.7%, mainly due to increased demand of cement and concrete. Revenues increased by 11.3%, in line with the increase in sales volume mentioned above.
INSIDER20:41:26·1d·Health Care·
$PCRX
Chief Financial Officer Cross Shawn exercised 12,941 shares at a strike of $16.45 and sold $325,596 worth of shares (12,941 units at $25.16) as part of a pre-agreed trading plan (SEC Form 4)
4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
PR20:30:00·1d·Finance·
$BANR
Banner Bank's Financial Health Earns National Forbes Recognition for 10th Straight Year
For the 10th straight year, Forbes has named Banner Bank one of the 100 Best Banks in America based on the bank's financial strength, profitability and growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424497348/en/Banner Bank receives Forbes recognition for 10th straight year "Being recognized by Forbes year after year reflects the disciplined way we run our business and the strength of our balance sheet," said Mark Grescovich, Banner Bank President and CEO. "It reaffirms our approach to banking is on the mark—to remain a consistent, reliable source of capital and a trusted partner for the people and businesses we serve
INSIDER20:24:27·1d·Industrials·
$NXT
Chief Legal & Compliance Ofc Ledesma Bruce was granted 76,220 shares and disposed of $3,168,141 worth of shares (26,129 units at $121.25) as part of a pre-agreed trading plan, increasing direct ownership by 26% to 245,880 units (SEC Form 4) (withholding tax)
4 - Nextpower Inc. (0001852131) (Issuer)
INSIDER20:24:06·1d·Industrials·
$NXT
Chief Accounting Officer Bennett David P disposed of $3,960,752 worth of shares (32,666 units at $121.25) as part of a pre-agreed trading plan and was granted 95,274 shares, increasing direct ownership by 48% to 193,575 units (SEC Form 4) (tax withholding)
4 - Nextpower Inc. (0001852131) (Issuer)